Trial Profile
Effectiveness and Safety of Firmagon in Androgen Ablative Therapy of Advanced Hormone-Dependent Prostate Carcinoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms FAST
- Sponsors Ferring Pharmaceuticals
- 25 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004051).
- 16 Jul 2012 Actual patient number changed from 671 to 673 as reported by ClinicalTrials.gov.